Orphanet: KEYNOTE 158: Ensayo clínico de evaluación de biomarcadores predictivos con pembrolizumab MK 3475 en pacientes con tumores sólidos avanzados Fase II
x

Search for a clinical trial

* (*) mandatory field

KEYNOTE-158: A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (Phase II) - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Merck sharp & dohme., inc.
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Hospital Universitari Vall d'Hebron
  • Paseo Vall d'Hebron, 119-129
  • 08035 BARCELONA
  • SPAIN
  • More information
  • Phone  : 34 93 489 30 00
  • Fax  : -
  • Website
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Hospital Universitario 12 de Octubre
  • Avenida de Crdoba s/n
  • 28041 MADRID
  • SPAIN
  • More information
  • Phone  : 34 91 3908000
  • Fax  : -
  • Website
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Hospital Universitario Ramn y Cajal
  • Carretera de Colmenar Viejo, Km. 9,1
  • 28034 MADRID
  • SPAIN
  • More information
  • Phone  : 34 91 336 80 00
  • Fax  : -
  • Website
Last update: May 2020

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.